These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19211640)

  • 1. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
    Bryce AH; Ketterling RP; Gertz MA; Lacy M; Knudson RA; Zeldenrust S; Kumar S; Hayman S; Buadi F; Kyle RA; Greipp PR; Lust JA; Russell S; Rajkumar SV; Fonseca R; Dispenzieri A
    Haematologica; 2009 Mar; 94(3):380-6. PubMed ID: 19211640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.
    Warsame R; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Leung N; Dingli D; Lust JA; Ketterling RP; Lin Y; Russell S; Hwa L; Kapoor P; Go RS; Zeldenrust SR; Kyle RA; Rajkumar SV; Dispenzieri A
    Blood Cancer J; 2015 May; 5(5):e310. PubMed ID: 25933374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.
    Hayman SR; Bailey RJ; Jalal SM; Ahmann GJ; Dispenzieri A; Gertz MA; Greipp PR; Kyle RA; Lacy MQ; Rajkumar SV; Witzig TE; Lust JA; Fonseca R
    Blood; 2001 Oct; 98(7):2266-8. PubMed ID: 11568015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
    Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
    Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).
    Bochtler T; Hegenbart U; Heiss C; Benner A; Moos M; Seckinger A; Pschowski-Zuck S; Kirn D; Neben K; Bartram CR; Ho AD; Goldschmidt H; Hose D; Jauch A; Schonland SO
    Blood; 2011 Apr; 117(14):3809-15. PubMed ID: 21310923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.
    Granzow M; Hegenbart U; Hinderhofer K; Hose D; Seckinger A; Bochtler T; Hemminki K; Goldschmidt H; Schönland SO; Jauch A
    Haematologica; 2017 Jul; 102(7):1281-1290. PubMed ID: 28341732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
    Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
    Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
    Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
    Cancer Med; 2021 Feb; 10(3):965-973. PubMed ID: 33347707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic abnormalities in monoclonal gammopathy of undetermined significance.
    Fonseca R; Bailey RJ; Ahmann GJ; Rajkumar SV; Hoyer JD; Lust JA; Kyle RA; Gertz MA; Greipp PR; Dewald GW
    Blood; 2002 Aug; 100(4):1417-24. PubMed ID: 12149226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
    Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
    Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.
    Harrison CJ; Mazzullo H; Ross FM; Cheung KL; Gerrard G; Harewood L; Mehta A; Lachmann HJ; Hawkins PN; Orchard KH
    Br J Haematol; 2002 May; 117(2):427-35. PubMed ID: 11972529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
    Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
    Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens.
    Bochtler T; Hegenbart U; Kunz C; Granzow M; Benner A; Seckinger A; Kimmich C; Goldschmidt H; Ho AD; Hose D; Jauch A; Schönland SO
    J Clin Oncol; 2015 Apr; 33(12):1371-8. PubMed ID: 25779559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.
    Chang H; Sloan S; Li D; Zhuang L; Yi QL; Chen CI; Reece D; Chun K; Keith Stewart A
    Br J Haematol; 2004 Apr; 125(1):64-8. PubMed ID: 15015970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category.
    Muchtar E; Dispenzieri A; Kumar SK; Ketterling RP; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
    Leukemia; 2017 Jul; 31(7):1562-1569. PubMed ID: 27904139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal abnormalities in systemic amyloidosis.
    Fonseca R; Ahmann GJ; Jalal SM; Dewald GW; Larson DR; Therneau TM; Gertz MA; Kyle RA; Greipp PR
    Br J Haematol; 1998 Dec; 103(3):704-10. PubMed ID: 9858220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytoplasmic light-chain immunofluorescence combined with FISH in bone marrow smears to detect cytogenetic abnormalities in multiple myeloma].
    Shi Y; Yang H; Guo R; Guo Z; Li JY; Wu YJ; Qiu HR
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jun; 45(6):566-570. PubMed ID: 39134488
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular cytogenetic aberrations in Tunisian patients with multiple myeloma identified by cIg-FISH in fixed bone marrow cells.
    Gmidène A; Avet-Loiseau H; Sennana H; Ben Abdallah I; Khlif A; Meddeb B; Elloumi M; Saad A
    Cytogenet Genome Res; 2012; 136(1):44-9. PubMed ID: 22188899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.